CMV ANTIGENAEMIA AS A MARKER OF TARGETING CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ULCERATIVE COLITIS

(1) HYOGO COLLAGE OF MEDICINE



This item was part of the IBD I session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A191